Evaluating the Relationship Between Serum Level of Interleukin-6 and Rheumatoid Arthritis Severity and Disease Activity.
Adolescent
Adult
Aged
Anti-Citrullinated Protein Antibodies
/ immunology
Arthritis, Rheumatoid
/ immunology
Blood Sedimentation
C-Reactive Protein
/ immunology
Cross-Sectional Studies
Female
Humans
Interleukin-6
/ immunology
Male
Middle Aged
Rheumatoid Factor
/ immunology
Severity of Illness Index
Young Adult
DAS-28
Interleukin 6
cardiomyocytes
cytokine
glycoprotein
rheumatoid arthritis
Journal
Current rheumatology reviews
ISSN: 1875-6360
Titre abrégé: Curr Rheumatol Rev
Pays: United Arab Emirates
ID NLM: 101261938
Informations de publication
Date de publication:
2020
2020
Historique:
received:
12
10
2018
revised:
27
12
2018
accepted:
29
01
2019
pubmed:
8
2
2019
medline:
5
8
2021
entrez:
8
2
2019
Statut:
ppublish
Résumé
The aim of this study was to evaluate the relationship between Interleukin-6 (IL-6) serum level and the severity and activity of Rheumatoid Arthritis (RA). In this cross-sectional study, 120 RA patients referred to the rheumatology clinic, the patients were diagnosed by rheumatologists according to ACR / EULAR 2010 criteria. Based on DAS28 score the patients were divided into 4 groups: Remission, Mild, Moderate and Severe. Each group contained 30 patients. Serum levels of Erythrocyte Sedimentation Rate (ESR), C-Reactive Protein (CRP), anti-Cyclic Citrullinated Peptide (anti-CCP) and Rheumatoid Factor (RF) and serum levels of IL-6, were measured. The relationship between these factors was measured and compared to the relationship between IL-6 and these factors, and the activity of the disease was evaluated based on DAS-28. This study showed that the serum level of IL-6 has a significant relationship with RA activity according to DAS-28 (P value <0.001). There is also a significant relationship between the ESR level, the number of painful joints, and the number of swollen joints, and the severity of the disease based on VAS. Generally the findings of this study indicate that serum level of IL-6 plays an important role in the severity and activity of RA disease and can be considered as a determining factor in evaluating the severity of RA in RA patients and it is a good guide for a step up or down of treatment.
Identifiants
pubmed: 30727900
pii: CRR-EPUB-96405
doi: 10.2174/1573397115666190206144223
doi:
Substances chimiques
Anti-Citrullinated Protein Antibodies
0
IL6 protein, human
0
Interleukin-6
0
C-Reactive Protein
9007-41-4
Rheumatoid Factor
9009-79-4
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
249-255Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.